182
Universal Ibogaine Inc. Announces Board of Directors Update
Universal Ibogaine inc. has announced changes to its Board of Directors, with Peter Vlahos, Constantine Buzunis, adn Peter Ginakes having resigned from their positions. The company confirmed the current board composition includes Eric Hrimech, nia Killebrew, tony Wagner, James Duncan, and Nick karos. Universal Ibogaine is progressing with preparations to submit its clinical trial request to Health Canada, with a target submission date of the end of November 2025. The board’s expertise spans healthcare, clinical trials, finance, and law, supporting the company’s commitment to patient safety and its continued development.